Riepe F G, Krone N, Krüger S N, Sweep F C G J, Lenders J W M, Dötsch J, Mönig H, Sippell W G, Partsch C-J
Division of Pediatric Endocrinology, Department of Pediatrics, Christian-Albrechts-Universität Kiel, Kiel, Germany.
Exp Clin Endocrinol Diabetes. 2006 Mar;114(3):105-10. doi: 10.1055/s-2005-865836.
Patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency suffer from glucocorticoid and mineralocorticoid deficiency. They have insufficient epinephrine reserves and increased basal leptin levels and are often insulin resistant. In healthy subjects, an inhibitory effect of acute catecholamine elevation on the leptin plasma concentrations has been reported. However, it is not yet known how leptin levels respond to exercise in CAH patients.
We performed a cycle ergometer test in six CAH patients to measure the response of plasma leptin, glucose and the catecholamines, epinephrine (E) and norepinephrine (N), as well as their respective metabolites, metanephrine (M) and normetanephrine (NM), to intense exercise.
Baseline leptin concentrations in CAH patients were not different from those of controls. Leptin levels decreased significantly with exercise in healthy controls, whereas they remained unchanged in CAH patients. In contrast to controls, CAH patients showed no rise of plasma glucose. Basal and stimulated E and M levels were significantly lower in CAH patients compared to controls. Baseline and stimulated N and NM levels were comparable, showing a significant rise after exercise. Peak systolic blood pressure and peak heart rate in both groups were comparable.
CAH patients do not manifest exercise-induced leptin suppression. The most probable reason for this is their severely impaired epinephrine stress response. In addition, epinephrine deficiency is leading to secondary changes in various catecholamine dependent metabolic pathways, e. g., energy balance. Although obvious clinical sequelae are so far unknown, the catecholamine-deficient state and the resulting hyperleptinemia might contribute to the severity of the disease in CAH.
因21-羟化酶缺乏导致先天性肾上腺皮质增生(CAH)的患者存在糖皮质激素和盐皮质激素缺乏。他们的肾上腺素储备不足,基础瘦素水平升高,且常伴有胰岛素抵抗。在健康受试者中,已有报道急性儿茶酚胺升高对血浆瘦素浓度有抑制作用。然而,尚不清楚CAH患者的瘦素水平对运动如何反应。
我们对6例CAH患者进行了蹬车测力计测试,以测量血浆瘦素、葡萄糖以及儿茶酚胺、肾上腺素(E)和去甲肾上腺素(N)及其各自代谢产物间甲肾上腺素(M)和去甲间甲肾上腺素(NM)对剧烈运动的反应。
CAH患者的基线瘦素浓度与对照组无差异。在健康对照组中,瘦素水平随运动显著降低,而在CAH患者中则保持不变。与对照组不同,CAH患者的血浆葡萄糖未升高。与对照组相比,CAH患者的基础和刺激后的E及M水平显著降低。基线和刺激后的N及NM水平相当,运动后显著升高。两组的收缩压峰值和心率峰值相当。
CAH患者未表现出运动诱导的瘦素抑制。最可能的原因是他们的肾上腺素应激反应严重受损。此外,肾上腺素缺乏导致各种儿茶酚胺依赖性代谢途径发生继发性变化,例如能量平衡。尽管目前尚不清楚明显的临床后果,但儿茶酚胺缺乏状态及由此导致的高瘦素血症可能会加重CAH患者的病情。